Gail Boudreaux
CIK 1287920 · President and CEO · last filed 2026-07-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
UNH price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
INDIANAPOLIS, IN 46204
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ELV | President and CEO | 169,991 | $421.49 | $71.65M | -$13.59M | 8 | 2026-07-17 |
| TGT | Director | 12,192 | $148.01 | $1.80M | $0 | 6 | 2026-03-13 |
| Elevance Health, Inc. (ANTM) Delisted | President and CEO | 94,041 | $482.58 | $45.38M | $2.00M | 6 | 2022-03-03 |
| ZBH | Director | 2,095 | $96.06 | $201.2K | $250.0K | 41 | 2021-04-02 |
| ANTX | President and CEO | 11,104 | $3.86 | $42.9K | $0 | 1 | 2018-03-05 |
| XEL | Director | 1,780 | $78.14 | $139.1K | $50.0K | 29 | 2018-01-02 |
| NVAX | Director | 10,000 | $10.02 | $100.2K | $144.8K | 4 | 2017-03-20 |
| UNH | EVP & CEO, UnitedHealthcare | 184,731 | $410.39 | $75.81M | -$24.88M | 39 | 2014-09-25 |
| GENZ | Director | 5,000 | $37.31 | $186.5K | $0 | 6 | 2011-04-06 |
Recent Filings · Page 14 of 15
141 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-06-08 | UNH | Tax (F) | −12,479 | -$378.6K | EDGAR |
| 2010-02-11 | UNH | Grant (A) | +30,304 | $0 | EDGAR |
| 2010-02-05 | UNH | Tax (F) | −3,188 | -$106.2K | EDGAR |
| 2009-06-08 | UNH | Tax (F) | −12,479 | -$338.2K | EDGAR |
| 2009-06-05 | GENZ | Exer (M) | +2,500 | $0 | EDGAR |
| 2009-05-26 | GENZ | Mixed | +2,500 | $0 | EDGAR |
| 2009-02-25 | UNH | Grant (A) | +38,462 | $0 | EDGAR |
| 2008-07-28 | UNH | Buy (P) | +12,000 | $334.8K | EDGAR |
| 2008-06-09 | UNH | Grant (A) | +116,900 | $0 | EDGAR |
| 2008-05-23 | GENZ | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.